Outcomes and Toxicity of Stereotactic Radiotherapy in Non-small Cell Lung Cancer Patients With Interstitial Lung Disease: A Multicentre Cohort Study. [PDF]
CureusSherlock AJ +5 more
europepmc +1 more source
T cell antigen discovery using signaling and antigen presenting bifunctional receptors (SABRs) [PDF]
, 2019 Alok Joglekar +4 more
openalex +1 more source
Definitive single-fraction ablative radiotherapy for early-stage breast cancer: DESERT-I trial - a dose-escalation study protocol. [PDF]
Radiat OncolGadea-Quinteiro J +10 more
europepmc +1 more source
How to Safely Deliver Stereotactic Ablative Radiotherapy With High-Dose or Multi-agent Systemic Therapy. [PDF]
CureusBernard ME.
europepmc +1 more source
Mid-ventilation PTV approach for stereotactic ablative body radiotherapy in stage I non-small-cell lung carcinoma: Implementation of a single-system workflow. [PDF]
Tech Innov Patient Support Radiat OncolShields-Dowton K +4 more
europepmc +1 more source
A Dosimetric Comparison between BgRT-SABR Plans and C-Arm Linac-Based IGRT-SABR Plans for Lung and Bone Lesions [PDF]
D. Pham +7 more
openalex +1 more source
Biomarkers in Stereotactic Ablative Radiotherapy: Current Evidence and Future Directions. [PDF]
Int J Mol SciMetawe M +6 more
europepmc +1 more source
“SABR” KONSEPTINING INGLIZ TILIDAGI MAXSUS LUG‘ATLARDA BERILISHI
Laylo Xursanova
openalex +2 more sources
Outcomes of Stereotactic Ablative Radiation Therapy (SABR) for a Second Primary Lung Cancer (SPLC): Evidence in Support of Routine CT Surveillance [PDF]
, 2014 Cornelis J.A. Haasbeek +4 more
openalex +1 more source
SABR improves outcomes in men with recurrent oligometastatic prostate cancer [PDF]
, 2020 Tim Thomas
openalex +1 more source